BIOXCEL THERAPEUTICS INC (BTAI) Institutional Ownership Changes & 13F Activity

BIOXCEL THERAPEUTICS INC (BTAI). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Oaktree Capital Management, Vanguard Capital Management Llc, Oaktree Fund Advisors, Llc, Millennium Management Llc, and Citadel Advisors Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Citadel Advisors LlcBuy+149,220149,220$210.40KQ2 2026Sep 02, 2026
Beacon Pointe Advisors, LlcSell-40-0.2%18,837$26.56KQ2 2026Aug 18, 2026
Oaktree Capital ManagementBuy+1,139,060+472.3%1,380,248$1.95MQ2 2026Aug 14, 2026
Oaktree Fund Advisors, LlcBuy+202,672+472.3%245,585$346.27KQ2 2026Aug 14, 2026
Millennium Management LlcBuy+177,950+9.2%2,114,710$2.98MQ2 2026Aug 14, 2026
Jones Financial Companies LllpSell-68,650-52.1%63,139$82.71KQ2 2026Aug 14, 2026
Susquehanna International Group, LlpBuy+17,20017,200$24.25KQ2 2026Aug 14, 2026
Two Sigma Securities, LlcBuy+10,79610,796$15.22KQ2 2026Aug 14, 2026
&PartnersBuy+2,724+3.4%83,588$117.86KQ2 2026Aug 14, 2026
Barclays PlcBuy+1,4281,428$2.01KQ2 2026Aug 14, 2026
Wells Fargo & Company/MnBuy+18+0.4%4,337$6.12KQ2 2026Aug 14, 2026
Vanguard Capital Management LlcBuy+712,206+343.5%919,545$1.30MQ2 2026Aug 13, 2026
Ubs Group AgBuy+105,277+199.4%158,065$222.87KQ2 2026Aug 13, 2026
Vanguard Fiduciary Trust CoBuy+52,016+61.3%136,937$193.08KQ2 2026Aug 13, 2026
Headlands Technologies LlcBuy+25,55625,556$36.03KQ2 2026Aug 13, 2026
Northern Trust CorpBuy+20,005+55.1%56,318$79.41KQ2 2026Aug 13, 2026
Virtu Financial LlcBuy+15,96715,967$23.00KQ2 2026Aug 13, 2026
Morgan StanleySell-8,917-84.2%1,671$2.36KQ2 2026Aug 13, 2026
Bnp Paribas Financial MarketsSell-47-79.7%12$17.00Q2 2026Aug 13, 2026
Silver Grove Financial Group, Inc.Sell-3-0.9%331$468.00Q2 2026Aug 13, 2026
Stonex Group Inc.Buy+20,68420,684$29.16KQ2 2026Aug 12, 2026
Geode Capital Management, LlcBuy+12,083+5.2%242,251$341.91KQ2 2026Aug 12, 2026
Newedge Advisors, LlcBuy+1,3311,331$1.88KQ2 2026Aug 12, 2026
Jpmorgan Chase & CoBuy+4545$63.00Q2 2026Aug 12, 2026
Tower Research Capital Llc (Trc)Sell-1,491-86.8%227$320.00Q2 2026Aug 11, 2026
Diversify Advisory Services, LlcBuy+15,00015,000$13.01KQ2 2026Aug 10, 2026
Portfolio Strategies, Inc.Buy+4,653+38.2%16,831$23.73KQ2 2026Aug 10, 2026
Blackrock, Inc.Buy+95,151+112.9%179,433$253.00KQ2 2026Aug 07, 2026
Quadrature Capital LtdBuy+38,03838,038$53.63KQ2 2026Aug 07, 2026
Citigroup IncBuy+2,9982,998$4.23KQ2 2026Aug 03, 2026
Showing 30 of 38

Frequently asked questions about BTAI activity

  • Which institutional owners are buying BTAI?

    Institutional owners buying BTAI include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in BTAI activity?

    "Buy" means an investor increased their reported position in BTAI compared to the prior reporting period. This reflects growing exposure to BIOXCEL THERAPEUTICS INC (BTAI) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in BTAI increasing?

    Institutional interest in BTAI can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.